Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
Roger S. McIntyre, Joseph R. Calabrese
Current Medical Research and Opinion (2019) Vol. 35, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Bipolar disorders
Roger S. McIntyre, Michael Berk, Elisa Brietzke, et al.
The Lancet (2020) Vol. 396, Iss. 10265, pp. 1841-1856
Closed Access | Times Cited: 678
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 284
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management
Roger S. McIntyre, Martin Alda, Ross J. Baldessarini, et al.
World Psychiatry (2022) Vol. 21, Iss. 3, pp. 364-387
Open Access | Times Cited: 105
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression
Giovanni Martinotti, Bernardo Dell’Osso, Giorgio Di Lorenzo, et al.
Bipolar Disorders (2023) Vol. 25, Iss. 3, pp. 233-244
Open Access | Times Cited: 48
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 85
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes
Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, et al.
JAMA Psychiatry (2023) Vol. 81, Iss. 6, pp. 555-555
Open Access | Times Cited: 41
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
European Neuropsychopharmacology (2023) Vol. 70, pp. 49-55
Closed Access | Times Cited: 38
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses
Roger S. McIntyre, Suresh Durgam, S.G. Kozauer, et al.
European Neuropsychopharmacology (2023) Vol. 68, pp. 78-88
Open Access | Times Cited: 36
The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
Muhammad Youshay Jawad, Saleha Qasim, Menglu Ni, et al.
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 909-909
Open Access | Times Cited: 36
Machine learning based approaches for clinical and non-clinical depression recognition and depression relapse prediction using audiovisual and EEG modalities: A comprehensive review
Sana Yasin, Alice Othmani, Imran Raza, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106741-106741
Closed Access | Times Cited: 31
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea, et al.
Psychiatry Research (2023) Vol. 327, pp. 115378-115378
Open Access | Times Cited: 28
Clinical specificity profile for novel rapid acting antidepressant drugs
Mauro Scala, Giuseppe Fanelli, Diana De Ronchi, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 297-328
Open Access | Times Cited: 26
Systemic inflammation and oxidative stress markers in patients with unipolar and bipolar depression: A large-scale study
YanYan Wei, Huanqin Gao, Yanhong Luo, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 154-166
Closed Access | Times Cited: 23
Common and disease-specific patterns of functional connectivity and topology alterations across unipolar and bipolar disorder during depressive episodes: a transdiagnostic study
Hao Sun, Rui Yan, Zhilu Chen, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
Federica Pelacchi, Liliana Dell’Osso, Emi Bondi, et al.
Brain and Behavior (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 34
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D. Bandeira, Gustavo C. Leal, Fernanda S. Correia‐Melo, et al.
Journal of Psychiatric Research (2023) Vol. 164, pp. 229-234
Closed Access | Times Cited: 20
Anhedonia in bipolar depression treated with ketamine
Alina Wilkowska, Mariusz S. Wiglusz, Aleksandra Arciszewska, et al.
Bipolar Disorders (2024) Vol. 26, Iss. 4, pp. 356-363
Closed Access | Times Cited: 6
Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Farhan Fancy, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.
Bipolar Disorders (2022) Vol. 25, Iss. 2, pp. 99-109
Closed Access | Times Cited: 27
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis
Donovan A. Dev, Gia Han Le, Angela T.H. Kwan, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 480-488
Closed Access | Times Cited: 5
Meta‐analysis of sleep deprivation in the acute treatment of bipolar depression
John F. Gottlieb, Namni Goel, Shenghao Chen, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 4, pp. 319-327
Open Access | Times Cited: 37
S100A6 and Its Brain Ligands in Neurodegenerative Disorders
Anna Filipek, Wiesława Leśniak
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3979-3979
Open Access | Times Cited: 34
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 204-204
Open Access | Times Cited: 30
Peripheral biomarkers to predict the diagnosis of bipolar disorder from major depressive disorder in adolescents
Xiaohui Wu, Zhiang Niu, Yuncheng Zhu, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 5, pp. 817-826
Closed Access | Times Cited: 29
Adjunctive lumateperone ( ITI ‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial
Trisha Suppes, Suresh Durgam, S.G. Kozauer, et al.
Bipolar Disorders (2023) Vol. 25, Iss. 6, pp. 478-488
Open Access | Times Cited: 11
AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
Nicolas Salvetat, Francisco Jesus Checa-Robles, Aurélie Delacrétaz, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 385-393
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top